✦ LIBER ✦

Molecular targeting therapy for renal cell carcinoma

✍ Scribed by Masatoshi Eto; Seiji Naito

Publisher: Springer
Year: 2006
Tongue: English
Weight: 183 KB
Volume: 11
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-006-0577-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic relevance of the mTOR pathway

Prognostic relevance of the mTOR pathway in renal cell carcinoma : Implications for molecular patient selection for targeted therapy

✍ Allan J. Pantuck; David B. Seligson; Tobias Klatte; Hong Yu; John T. Leppert; La 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 980 KB

## Abstract ## BACKGROUND. The mammalian target of rapamycin (mTOR) pathway is up‐regulated in many human cancers, and agents targeting the mTOR pathway are in various stages of clinical development. The goal of the study was to evaluate the potential and limitations of targeting the mTOR pathway

Molecular markers of prognosis in renal

Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy

✍ Christopher G. Wood 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Targeted therapy in renal cell carcinoma

✍ Jean-Jacques Patard; Damien Pouessel; Karim Bensalah; Stéphane Culine 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 225 KB

Combination targeted therapy in advanced

Combination targeted therapy in advanced renal cell carcinoma

✍ Jeffrey Sosman; Igor Puzanov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

Molecular targeted therapy for hepatocel

Molecular targeted therapy for hepatocellular carcinoma

✍ Melanie Thomas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 150 KB

Targeting mTOR in renal cell carcinoma

✍ Gary R. Hudes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views